BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1006010)

  • 1. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
    Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
    Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clq binding circulating immune complexes in multiple sclerosis patients and their first-degree relatives: a distinctive immunological feature between sporadic and familial cases.
    Trouillas P; Vincent C; Revillard JV
    J Clin Lab Immunol; 1980 Sep; 4(2):77-81. PubMed ID: 7441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.
    Engstrom JF; Arvanitakis C; Sagawa A; Abdou NI
    Gastroenterology; 1978 Apr; 74(4):747-51. PubMed ID: 415931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.
    Srivastava LM; Agarwal DP; Goedde HW; Rohde R
    Tropenmed Parasitol; 1975 Jun; 26(2):212-8. PubMed ID: 1162738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H
    Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological study in sickle cell disease patients: importance of the complement system].
    Sassi F; Bardi R; Neji T; Ayed K; Ben Dridi MF
    Tunis Med; 2003 Mar; 81(3):195-9. PubMed ID: 12793071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE and complement in allergic children.
    Costa Trindade J; Palma-Carlos ML; Palma-Carlos AG; César-Ramos JM; Ribeiro L; Ferreira NG
    Allergol Immunopathol (Madr); 1978; 6(6):520-6. PubMed ID: 752256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune profile of women experiencing recurrent spontaneous abortions of unknown aetiology.
    Kilpatrick DC; Liston WA; Neill G; Maxwell C
    Dis Markers; 1989; 7(2):87-94. PubMed ID: 2731410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
    Cagatay T; Bilir M; Gulbaran M; Papila C; Cagatay P
    Kobe J Med Sci; 2003; 49(5-6):99-106. PubMed ID: 15141145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement abnormalities during an epidemic of group B meningococcal infection in children.
    Beatty DW; Ryder CR; Heese HD
    Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.